Mr. Ian Gazard
Ian has spent a career in finance working at BlueMountain Capital, JP Morgan, and Moody’s Investor Service. Most recently he was a long/short equity and credit analyst at BlueMountain Capital, a New York-based fund with over $15 billion in assets under management.
Since leaving BlueMountain, Ian focuses on investing in synthetic biology companies, and collaborating with impactful NGO’s, particularly in agriculture and technology. He is on the advisory board of the Cornell Alliance for Science, a non-profit focused on crop biotechnology in the developing world and a Partner at Acumen, a combination of venture capital and philanthropy changing the way the world tackles poverty. He is also on the New York Leadership Committee of The Nature Conservancy, a leading environmental group.